John Öhd

John Öhd

Chief Executive Officer chez MODUS THERAPEUTICS HOLDING AB

53 ans
Health Technology
Consumer Services
Commercial Services

Profil

John Öhd occupies the position of Chief Executive Officer of Modus Therapeutics Holding AB, Chief Executive Officer at Modus Therapeutics AB (a subsidiary of Modus Therapeutics Holding AB) and Chief Scientific Officer & Venture Partner at Karolinska Development AB.
He is also on the board of Umecrine Cognition AB, Svenska Vaccinfabriken Produktion AB and AnaCardio AB.
In the past Dr. Öhd held the position of Chief Medical Officer of Medivir AB, Group Director-Development at AstraZeneca AB and Senior Director-Experimental Medicine at Shire Sweden AB.
He received a doctorate from the University of Linköping and a doctorate from the University of Lund.

Postes actifs de John Öhd

SociétésPosteDébut
KAROLINSKA DEVELOPMENT AB Chief Tech/Sci/R&D Officer 01/06/2020
MODUS THERAPEUTICS HOLDING AB Chief Executive Officer 01/01/2020
Chief Executive Officer -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Tous les postes actifs de John Öhd

Anciens postes connus de John Öhd

SociétésPosteFin
MEDIVIR AB Chief Tech/Sci/R&D Officer 15/07/2018
Corporate Officer/Principal -
Shire Sweden AB Corporate Officer/Principal -
Voir l'expérience en détail de John Öhd

Formation de John Öhd

University of Linköping Doctorate Degree
University of Lund Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de John Öhd

Relations

68

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
MEDIVIR AB

Health Technology

KAROLINSKA DEVELOPMENT AB

Finance

MODUS THERAPEUTICS HOLDING AB

Health Technology

Entreprise privées6

Commercial Services

Health Technology

Health Technology

Health Technology

Shire Sweden AB

Health Technology

Voir les connexions sociétés